Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription
(Q28204517)
scientific article (publication date: 15 February 2001)
scientific article (publication date: 15 February 2001)
Language: